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Executive Summary 
In proposed action steps to address the National HIV/ 
AIDS Strategy goal of reducing new HIV infections, the
Federal Implementation Plan for the Strategy specifically
encourages improved surveillance to better characterize
HIV among American Indians and Alaska Natives (AI/ 
AN). The Implementation Plan calls for the Centers for
Disease Control and Prevention (CDC) to provide state
health departments that have high concentrations of
AI/AN populations with recommendations on effective
HIV surveillance activities. To develop these recom­
mendations, CDC followed a two-step process. First, an
assessment was conducted from July through September
2011, including a literature review and a series of
discussions with representatives of AI/AN public health
agencies and organizations and the Indian Health
Service (IHS), as well as several state health departments.
Second, current AI/AN-related HIV surveillance
practices were assessed through focus group and key
informant discussions with HIV surveillance staff in six
states and three cities within them that have separately
funded HIV surveillance programs and have the largest
populations or proportions of AI/AN persons (Alaska,
Arizona, California, New Mexico, Oklahoma, Texas
and Los Angeles, San Francisco and Houston). Five
areas for improvement of HIV surveillance among AI/ 
AN were identified from the literature and discussions
with staff in the jurisdictions: 1) ascertainment of HIV
infection;  2) reporting of diagnoses to surveillance; 3)
identification of the race/ethnicity of reported cases; 4)
effectiveness of data presentation in surveillance reports;
and 5) dissemination of AI/AN surveillance data.
The literature review, focus groups and key informant
interviews also identified action steps to improve HIV
surveillance among AI/AN including: 1) routine or
periodic linkage of HIV surveillance data to other
databases (such as tribal membership rolls or the IHS
National Patient Registration System (NPRS) to correct
race/ethnicity misidentification; 2) combining several
years of data and reporting AI/AN-specific data rather
than subsuming these data under an “other” race/ 
ethnicity category; 3) working through a Tribal Liaison,
Indian Health Board (IHB), or Tribal Epidemiology
Center (TEC) to identify data needs of AI/AN Tribes,
communities, and non-governmental organizations; 4)
accommodating these data needs through analysis of
surveillance data by zip code or county to approximate
the boundaries of  tribal lands or communities; and 5)
establishing formal and informal agreements, including
provisions for data sharing to ensure that data reach
those empowered to use them for public health action in
AI/AN communities.
The applicability and feasibility of these suggested
improvements were discussed with the HIV surveillance
coordinators in states and cities that participated
in this assessment.  Some approaches to addressing
needed improvements in surveillance were found to be
applicable to or feasible in some jurisdictions and not
others. Based on the findings of the assessment, five
standard practices should be implemented:
1. Promote protocols for routine, opt-out HIV testing
 
in accordance with CDC recommendations;
 
2. Identify  	providers serving AI/AN patients, 
including social service providers, community based
organizations (CBOs),  and laboratories conducting
HIV testing of AI/AN persons, and follow up to
encourage the reporting of  all positive HIV tests to
local or state health departments; 
3. Present, in surveillance reports, cases with
documented single AI/AN race (AI/AN only without
Hispanic ethnicity), and separately, present AI/AN
cases with and without Hispanic ethnicity;
4. Analyze and present summary information on AI/ 
AN annually, separately from other races/ethnicities,
if numbers of cases are sufficiently large, according
to data release guidelines; otherwise, combine data
across years;
5. Send AI/AN HIV surveillance reports and summary
information directly to AI/AN Tribes, agencies and
organizations that have expressed a need for this
information. 
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Furthermore, CDC identified 15 recommended practices
supporting effective HIV surveillance among AI/AN:
1. Expand testing and encourage testing outreach to
AI/AN persons through AI/AN Tribes, agencies, and
organizations;
2. Utilize available culturally appropriate “know your
status” and HIV awareness materials directed toward
AI/AN;
3. Present AI/AN HIV surveillance information to
 
AI/AN Tribes, agencies, and organizations, and
 
emphasize the importance of complete reporting,
 
including reporting of risk factors, for improved
 
usefulness of the data;
 
4. Promote HIV case reporting by facilities serving

AI/AN persons, including establishment of
 
agreements between state health departments and
 
tribal and community-based organizations that
 
provide HIV testing; conduct special studies to
 
evaluate completeness of reporting.
 
5. Develop formal data sharing agreements between
 
state health departments, IHS/Tribal/Urban health
 
facilities, and tribal organizations, in accordance
 
with current data security and confidentiality
 
guidelines, to strengthen collaboration on
 
surveillance;
 
6. Identify ways to encourage more accurate
documentation of race/ethnicity in medical records;
7. Utilize data sources with self-reported or family-

reported race, such as Ryan White program data,
 
to improve the completeness and accuracy of race/
 
ethnicity in surveillance data;
 
8. Contact providers for race/ethnicity information
when the case report indicates non-AI/AN race and
diagnosis has occurred in an IHS-funded,
AI/AN-focused CBO, or tribally operated facility, or
there is other information suggestive of AI/AN race;
9. Partner with Tribes, IHBs, TECs and IHS to identify
and correct misidentification of race/ethnicity
by periodically linking HIV surveillance data
with tribal membership rolls or the IHS patient
registration system;
10. Work with AI/AN Tribes, IHBs, and TECs as well as
non-governmental AI/AN-serving organizations to
identify HIV surveillance information needed and
address these needs;
11. Produce and disseminate AI/AN-focused HIV
reports or fact sheets using local HIV surveillance
data;
12. Partner with Tribes, IHBs, AI/AN-focused CBOs,
and TECs to conduct within-jurisdiction regional
analyses that cover areas of high concentration of
AI/AN people;
13. Collaborate with other states and Tribes, IHBs,
AI/AN-focused CBOs, and TECs to combine
data for broader regional analyses of AI/AN HIV
surveillance data 
14. Proactively identify and offer assistance to AI/ 
AN Tribes, agencies, and organizations that have
information needs and/or technical assistance or
capacity building assistance related to interpreting
and using HIV surveillance data;
15. Promote the use of AI/AN HIV surveillance data
through presentations to HIV prevention planning
groups, health care providers that serve AI/AN, and
AI/AN-focused prevention programs.
Introduction 
The three primary goals of the National HIV/AIDS
Strategy (NHAS) are: 1) reducing the number of
people who become infected with HIV, 2) increasing
access to care and optimizing health outcomes for
people living with HIV, and 3) reducing HIV-related
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health disparities.1 To achieve these goals, the Federal
Implementation Plan for the Strategy specifically
encourages improved surveillance  to better characterize
HIV among smaller populations such as American Indians
and Alaska Natives (AI/AN) and calls for the Centers for
Disease Control and Prevention (CDC) to provide state
health departments that have high concentrations of AI/ 
AN populations with recommendations on effective HIV
surveillance activities.2 This report provides these recom­
mendations and describes the activities that led to their
development.
Background 
According to the 2010 U.S. Census, a total of 5.2 million
individuals reported their race as AI/AN, representing
1.7% of the U.S. population, including 2.9 million
reporting AI/AN race alone and 2.3 million reporting
AI/AN in combination with one or more other races.3 
Between 2000 and 2010, the AI/AN population grew by
1.1 million, a 26.7% increase; the overall U.S. population
grew by 9.7% in comparison. Hispanic or Latino
ethnicity was reported by 1.2 million AI/AN (23%). In
2010, the median age of AI/AN persons was 29 years
as compared with 37 years for the U.S. population as
a whole. More than one-fifth (22%) of AI/AN persons
lived in American Indian areas or Alaska Native Village
Statistical Areas. Forty percent of AI/AN adults and
adolescents lived in rural areas in the United States in
2008 compared with 16% of other race/ethnicity groups
combined.4 The population of AI/AN, including those of
more than one race, is projected to grow to 8.6 million
and comprise 2% of the U.S. population by 2050.3 
The AI/AN population is heterogeneous, including
566 federally recognized tribes with sovereign status
as domestic, dependent nations and with different
languages, cultures, and tribal governance structures, as
well as varied social, historical and economic conditions
that affect social determinants of health.3,5 Some  states
recognize tribes that are not federally recognized.6 
In addition to health care services received from the
private and public providers who serve other Americans,
AI/AN persons from federally recognized Tribes are
eligible for care under the federally funded Indian Health
Service (IHS). Health care services were provided to
2 million AI/AN persons in 2012 by programs funded
by the IHS; some of these programs are operated by
IHS and some are tribally operated or operated as
urban Indian health centers, and these programs are
collectively referred to as I/T/U facilities.5,7 State laws
regarding reporting of new HIV diagnoses apply equally
to providers and laboratories serving I/T/U facilities as
to other providers licensed in states. Although it is in
the best interest of a facility to report HIV cases (e.g., to
document numbers of HIV cases for funding purposes),
facilities may not be legally compelled to do so and their
voluntary HIV case reporting practices may vary. 
HIV Surveillance 
Although the annual numbers of new diagnoses of HIV
infection among AI/AN remain relatively low compared
with other race/ethnicity groups, AI/AN diagnosis
rates per 100,000 population are higher than those for
whites and Asians.8 Moreover, AI/AN have a shorter
survival time after diagnosis. Among AI/AN diagnosed
during 1996-2005, 47.2% received an AIDS diagnosis
within 3 years of initial HIV diagnosis (an indicator
of late diagnosis), a higher percentage than for whites
(42.6%) and black/African Americans (46.1%) and a
lower percentage than for Hispanics/Latinos (48.4%) and
Asians (50.4%).9 AI/AN diagnosed during 2002-2006
were less likely to survive 12, 24 or 36 months after HIV
diagnosis compared with any other single race or ethnic
group.8 
The effectiveness of the HIV case surveillance system
for AI/AN depends on a number of factors: HIV
test-seeking behaviors of individuals and testing
practices of providers; AI/AN access to HIV testing;
case reporting to state systems by providers, laboratories
and facilities; correct identification of AI/AN race;
appropriate data analysis methods; and dissemination
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of surveillance information useful for prevention
and community health-care planning. A greater
estimated percentage of AI/AN infected with HIV were
undiagnosed by the end of 2008, compared with whites,
blacks/African Americans, and Hispanics/Latinos,
which may reflect  lower HIV testing access, uptake, or
coverage among AI/AN at risk for HIV.10 One survey
of urban AI/AN at higher risk for HIV found that 44%
of those who reported high-risk behaviors perceived
themselves to have low or no risk for HIV, even though
most had received HIV prevention messages.11 These
findings suggest that culturally appropriate educational
initiatives to encourage accurate perception of HIV risk
may help to improve uptake of HIV testing among AI/ 
AN. Risk factor information was missing for 26% of AI/ 
AN diagnosed in 2010 (unadjusted) and approximately
73% of diagnoses of HIV infections among AI/AN males
could be attributed to male-to-male sexual contact
(adjusted for missing risk factor).8  Improved risk factor
ascertainment by clinicians submitting case reports can
contribute important information to guide prevention
and outreach efforts.
Concerns have been raised about whether all diagnoses
of HIV among AI/AN persons are reported as required
by state laws.7 In surveys of AI/AN and state health
agencies, respondents raised the possibilities that lack
of trust, particularly between tribal authorities and
state or local governments, and a lack of mutually
agreed-upon arrangements for reporting cases across
state-tribal jurisdictional boundaries may be barriers
to reporting cases to surveillance.12,13 Underreporting
could be occurring in some geographic areas, although
to date there have been no published studies evaluating
completeness of reporting.7 However, there is evidence
that racial misidentification may cause considerable
underestimation of AI/AN HIV cases.14-17 One study of
racial misidentification in HIV/AIDS reporting systems
in five states and one urban county found that 4% to
55% of AI/AN persons with reported diagnoses across
these jurisdictions had been misidentified as not being
of AI/AN race in HIV surveillance case records.15 
Different methods of defining AI/AN and reporting
HIV diagnoses by race/ethnicity groups can affect
the availability of information on HIV among AI/AN
for policy, prevention and health care planning for
affected AI/AN communities. In 2002, the Office of
Management and Budget (OMB) recommended that
diverse small groups like AI/AN not be combined with
other groups in race/ethnicity categories because these
combined data offer minimal useful information for
public health programs.14 The effect of HIV on AI/ 
AN communities may be underestimated by race/ 
ethnicity reporting conventions for HIV surveillance in
which individuals of any race with Hispanic ethnicity
are counted in the “Hispanic, all races” group, and
individuals without Hispanic ethnicity but who report
more than one race are classified in the “Multiple Race”
group. These reporting conventions have a greater
effect on HIV surveillance among AI/AN than other
races because of the higher proportion of mixed race/ 
ethnicity reported by persons identifying themselves
as AI/AN (44% in the 2010 Census, compared with 3%
among all races).3 Also, published surveillance data
analyzed by county or state may not be meaningful for
AI/AN Tribes and communities with boundaries that do
not coincide with county or state borders.13 
HIV Surveillance Systems 
HIV Case Surveillance 
Within the first few years of the HIV epidemic in the
United States, all U.S. states, the District of Columbia,
and the U.S. dependent areas were reporting diagnoses
of acquired immunodeficiency syndrome (AIDS) to
CDC using a standardized system.10 In 1994, CDC
expanded the national surveillance system to include
diagnoses of both HIV infection and AIDS, and 25
states with confidential name-based HIV infection
reporting began submitting case reports to CDC.
Over time, additional areas implemented confidential
name-based HIV surveillance and all states, the District
of Columbia and 5 dependent areas had implemented
such surveillance by April 2008. The latest adjusted
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estimates of diagnoses of HIV infection published
in the National HIV Surveillance Report include 46
states and 5 dependent areas that have had confidential
name-based HIV reporting since January 2007,
including all of the states with large AI/AN populations.
The estimates are limited to these 51 jurisdictions to
allow for statistical adjustments for reporting delays.8 
Beginning in 2012, data from all states are expected to
be included in national reports. All cases are reported
to CDC without identifying information. National
HIV case surveillance also includes the collection of
supplemental data in states funded for HIV Incidence
Surveillance (HIS), Variant, Atypical and Resistance
HIV Surveillance (VARHS), and Geocoding and Linkage
Activities with HIV Data (GLAHD). 
For most data analyses, national HIV surveillance
reports follow conventions that place AI/AN persons
who are also Hispanic into the Hispanic/Latino category
and persons reported as both AI/AN and another
reported race into the Multiple Races category.8 
Medical Monitoring Project
The Medical Monitoring Project (MMP) is a national,
population-based surveillance system that collects
information on clinical outcomes and behaviors of
HIV-infected persons receiving care in the United
States.18 Collection of data from interviews with
HIV-infected patients provides information on current
levels of behaviors that may facilitate HIV transmission;
patients’ access to, use of, and barriers to HIV-related
secondary prevention services; utilization of HIV-related
medical services; and adherence to drug regimens.
Through abstraction of medical records, MMP also
provides information on clinical conditions that occur in
HIV-infected persons as a result of their disease or the
medications they take, receipt of HIV care and support
services, and the quality of these services. Less than 1%
of MMP respondents in the 2007 MMP data collection
cycle were AI/AN.18 
National HIV Behavioral Surveillance System
The National HIV Behavioral Surveillance System
(NHBS) is CDC’s most comprehensive system for
conducting behavioral surveillance among persons at
highest risk for HIV infection in the United States.19 
The overall strategy for NHBS involves conducting
rotating annual cycles of surveillance in three different
populations at high risk for HIV: men who have sex
with men (MSM), injection drug users (IDUs) and
heterosexuals at increased risk for HIV. Surveillance
is conducted in 20 cities in the United States which
have high AIDS prevalence. NHBS collects detailed
information on HIV risk behaviors, HIV testing and
use of prevention services. AI/AN represented <1%
of respondents from the first and second NHBS data
collection cycles among MSM and the first cycle among
IDUs.20-22
Methods 
CDC conducted a literature review to: 1) identify
gaps in and barriers to surveillance of HIV infection
among AI/AN; 2) explore suggestions for improving
surveillance; 3) describe what is being done to enhance
HIV surveillance among AI/AN in the United States and
Canada; 4) examine practices to enhance surveillance for
other health conditions among AI/AN; and 5) identify
models for sharing surveillance data with AI/AN tribal
organizations and communities. We selected six states
and three cities within these states that have separately
funded HIV surveillance programs; these areas have the
largest populations or proportions of AI/AN persons
in the United States (Alaska, Arizona, California, New
Mexico, Oklahoma, Texas, Los Angeles, San Francisco
and Houston). HIV surveillance staff in the selected
jurisdictions were contacted to assess, through group
discussions, the current AI/AN-related HIV surveillance
practices and the feasibility of suggested improvements.
The assessment was focused on the needs for
improvement identified through literature review and by
the representatives of AI/AN agencies. These activities
led to our proposed recommendations for improving
HIV surveillance among AI/AN.  Through the literature
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review and a series of group dialogs, conference calls, and
key informant discussions with representatives of AI/AN
public health agencies and organizations, AI/AN-focused
community based organizations (CBOs), and IHS, we
identified needed improvements in HIV surveillance among
AI/AN and action steps to effect these improvements. 
Summary of Key Findings on Improving 
Surveillance of HIV Infection among
AI/AN Persons 
CDC identified five areas for improvement related to
surveillance of HIV infection among AI/AN from the
literature review, group discussions and key informant
interviews. These include improving: 1) ascertainment
of HIV infection; 2) reporting of diagnosed cases to
health departments; 3) identification of the race/ethnicity
on case reports; 4) effectiveness of  data presentation
in surveillance reports (particularly the practice of
subsuming AI/AN reported cases into an “other” race/ 
ethnicity category and into geographic areas that do not
reflect concentrations of AI/AN people or I/T/U service
areas; and 5) dissemination of AI/AN surveillance data so
that those data reach those in a position to use the data for
decision making about HIV prevention and care. 
The literature review, group discussions and key
 
informant interviews also identified action steps to
 
improve surveillance among AI/AN, including: 1)
 
routine or periodic linkage of HIV surveillance data to
 
other databases (such as tribal membership rolls or the
 
IHS NPRS) to correct race/ethnicity misidentification;
 
2) combining several years of data and reporting AI/
 
AN-specific data rather than subsuming these data
 
under an “other” race/ethnicity category; 3) working
 
through a Tribal Liaison, Indian Health Board (IHB),
 
or Tribal Epidemiology Center (TEC) to identify data
 
needs; 4) accommodating data needs of AI/AN Tribes
 
and organizations through analysis of data by zip code
 
or county to approximate the boundaries of tribal lands
 
or communities; and 5) establishing formal or informal
 
data-sharing agreements to ensure that data reach those
 
empowered to use them for public health action in AI/ 
AN communities.
The six state surveillance programs interviewed for
this report vary widely with respect to the geographic
distribution patterns of AI/AN persons within their
jurisdictions, such as the existence of geographic
concentrations of AI/AN individuals, the size of
communities with a high proportion of AI/AN persons
and whether there are separate, tribal jurisdictions
(federally or state-recognized) contiguous with state
boundaries.
Findings from the literature review, group discussions,
and key informant interviews with representatives of
AI/AN agencies and IHS indicated that the geographic
concentration of AI/AN in communities and the
presence of government-funded health services
may determine where HIV diagnoses are made and
the quality of the information in case reports from
facilities providing diagnoses. For example, IHS,
tribally operated, and CBO facilities performing HIV
testing may report AI/AN race more accurately than
do facilities that provide health care services to more
general populations, regardless of AI/AN identity.
In contrast, states with geographically dispersed AI/ 
AN populations receiving testing at facilities that are
neither funded by IHS nor tribally operated have fewer
opportunities to develop a systematic means to correct
racial misidentification of AI/AN.
Surveillance also depends on strong case-reporting
relationships between providers from health-care
facilities and nonclinical HIV testing facilities where
HIV diagnoses are made and state and local health
departments. The strength of these relationships may
vary across facilities serving AI/AN persons within
a surveillance jurisdiction and across jurisdictions.
In addition, if HIV testing is performed on tribal
lands adjacent to more than one state, jurisdictional
issues may hinder reporting of diagnoses. Because of
differences in the distribution of AI/AN communities,
access points for HIV testing, case reporting and
10 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
case-reporting relationships, and the overall numbers
of reported AI/AN HIV cases across jurisdictions,
some approaches to improving surveillance may be
more applicable or feasible for some jurisdictions than
others. We therefore focused group discussions with
HIV surveillance staff in the six selected jurisdictions
on identifying approaches that were both applicable and
feasible in their jurisdictions. Key findings from these
discussions are presented below.
1. Case Ascertainment —Timely and accurate
ascertainment (case identification) is essential
to effective public health surveillance, including
HIV surveillance. Ascertainment of HIV infection
in AI/AN populations may be improved through
general expansion of HIV testing or through testing
that is specifically targeted toward reaching AI/ 
AN, especially those at highest risk, for example
male-bodied Two-Spirit persons or MSM. The IHS
National HIV/AIDS Administrative Work Plan
2008-2011 recommends routine HIV testing.23,24 IHS
Women’s Health Guidelines issued in 2005 included
a performance standard for opt-out prenatal
screening to increase the number of AI/AN persons
who know their status and to decrease mother­
to-child transmission.24,25 A recent collaboration
between CDC and IHS has resulted in new IHS
guidelines for sexually transmitted disease (STD)
screening, including HIV testing.26 However, our key
informant interviews suggested that these guidelines
have not yet been widely implemented. Because
reporting of cases to surveillance is conditional on
diagnosis of infection, some informants suggested
that HIV testing programs and surveillance units of
state health departments collaborate more closely
to  increase provider awareness of HIV testing
guidelines, particularly  in rural settings where there
are challenges associated with testing and reporting
cases and where many AI/AN reside. 
In addition to routine HIV testing in clinics and by
providers who serve AI/AN patients, the literature
supports offering testing in non-clinical venues
(e.g., community-based organizations, schools,
community awareness events) and promoting
opt-out testing at other sites (e.g., correctional
facilities, substance abuse treatment centers).27 
Both the published literature and key informants
mentioned the reluctance of many AI/AN to
be tested in their local communities because of
confidentiality concerns and stigma. Specific
considerations related to confidentiality may apply
to opt-out testing, especially in facilities located on
reservations and in small communities. Culturally
appropriate social marketing is needed to make HIV
testing more routine and acceptable.
2. Case Reporting – State and city HIV surveillance
coordinators interviewed noted that new cases,
including diagnoses among AI/AN persons, were
usually reported by laboratories, not health-care
providers. At least one state reported that small
laboratories that serve I/T/U facilities did not
report all positive tests. Although clinicians and
laboratories serving I/T/U facilities are subject to
the same reporting laws as other laboratories and
clinicians licensed in a state, some HIV surveillance
coordinators who participated in our assessment
were uncertain whether all cases diagnosed in I/T/U
sites are being reported. Some key informants noted
that confusion about case reporting responsibilities
may contribute to underreporting when a person is
diagnosed on tribal lands or in a state other than his
or her state of residence. Others suggested special
studies for HIV case finding as well as data sharing
with IHS, tribal health organizations, and CBOs to
improve reporting of AI/AN HIV diagnoses. 
3. Identification of AI/AN Race – The literature
review yielded examples of linking HIV surveillance
and other public health surveillance databases with
other data sources that may have more accurate
race/ethnicity information and have been used to
correct misidentified race/ethnicity.28-29 Some of the
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key informants reported conducting such linkages
and finding them useful, but they also noted that
these linkages are labor intensive and that the
capacity to perform them routinely is limited. Some
key informants suggested assuming AI/AN race
when a case with unspecified AI/AN race/ethnicity
is reported from an IHS-funded facility. Others
pointed out that assuming all cases reported from
IHS-funded facilities are of AI/AN race may be
problematic because Commissioned Corps officers
and non-AI/AN family members may be allowed
access to IHS-funded care. Some key informants
emphasized that the AI/AN race of a relatively large
number of AI/AN persons with Hispanic or Latino
ethnicity is often missed in analyses of surveillance
data.  By convention, most analyses assign all
persons with Hispanic/Latino ethnicity, including
AI/AN persons, as Hispanic/Latino (i.e., individuals
who are both AI/AN and Hispanic/Latino are not
counted in the AI/AN group). Several jurisdictions
suggested that surveillance data be analyzed to
reflect all AI/AN (with and without Hispanic/Latino
ethnicity) as well as in the conventional way.
4. Presentation of AI/AN HIV Surveillance
Data – Surveillance staff noted challenges in
displaying data for small numbers of AI/AN in
annual and supplemental surveillance reports.
Several informants mentioned concerns that AI/ 
AN cases are displayed in the ‘other’ race/ethnicity
category, rendering information specific to AI/ 
AN inaccessible. Suggestions included creating
special reports on AI/AN using merged data from
several years, so that data on small populations
can be presented without violating confidentiality
and data release standards. Several jurisdictions
independently suggested that reporting all AI/AN,
including those with Hispanic/Latino ethnicity,
might help to address this problem. 
5. Dissemination of AI/AN HIV Surveillance
Information – HIV surveillance staff and the
literature review suggested that HIV reporting could
be strengthened by better collaboration with tribal
health departments and organizations through
mutual recognition of each other’s functions, needs,
and vested interests in the data, and through data
sharing.30,31 Some states have formal data-sharing
agreements or memoranda of agreement (MOA)
with Tribes, such as the agreement between the
Arizona Department of Public Health and the
Gila River Indian Community.32 Other state health
departments have informal data-sharing agreements
with TECs, IHS, IHBs, and Urban Indian Health
Programs. The few formal data sharing agreements
described were usually created for one-time
studies or activities. Some data-sharing agreements
currently in effect that pertain to sexually
transmitted diseases could be expanded to include
HIV. Programs choosing to share data should do
so in accordance with current data security and
confidentiality guidelines.33 
Furthermore, the HIV Surveillance Coordinators
and other informants reported that data sharing
with tribal organizations, community planning
groups and health-care providers is valuable
for prevention and care planning. Some tribal
leaders are not aware that HIV is a problem in
their jurisdiction. The importance of sharing
surveillance reports and summary information
with Tribes and tribal leaders was mentioned by
some HIV surveillance staff, but these activities are
apparently not being conducted by all states with
adjacent federal and state-recognized AI/AN tribal
jurisdictions.
Although some state health departments provide
reports upon request to Tribes and groups
concerned with AI/AN health, and some include
tribal leaders and health care providers in routine
mailings of their standard HIV Surveillance
Report, most do not routinely provide specific AI/ 
AN-focused reports to HIV prevention community
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planning groups. Some surveillance staff reported
having a Tribal Liaison in their state, but that this liaison
has not been asked to work on health-related issues like
HIV surveillance.  Other surveillance staff did not know
if their health department did or did not have a Tribal
Liaison but agreed a liaison could be useful for better
communication with Tribes.
Whereas some cities had data-sharing agreements with
urban AI/AN clinics, others were unaware of urban
clinics that operate in their jurisdictions. Because
approximately 50% of AI/AN HIV cases are diagnosed
in metropolitan areas, the potential for improving
surveillance by working with IHS-funded or other
urban Indian health programs may be underappreciated.
Misidentification of race/ethnicity may be more
common among AI/AN persons living in urban areas vs.
rural areas (or on reservations)15, and working with the
urban Indian health programs may be a way to address
this problem.
The legal environment surrounding the exchange
of identifiable health data between state health
departments and TECs for lawful public health activities
conducted by the TECs has been explored by Hodge
et al., in a recent report to the Council of State and
Territorial Epidemiologists. The authors concluded that
“legal barriers that thwart these data-sharing practices
should be assessed within each jurisdiction and
remedied, where possible, through legal interpretations
or tools discussed in this report, or approved in each
jurisdiction.”34 
Recommendations 
According to the Federal Implementation Plan of the
 
NHAS, CDC is tasked with making recommendations
 
to state health departments for effective AI/AN
 
HIV surveillance activities. Recognizing that some
 
approaches may be applicable in some jurisdictions
 
but not others, and approaches that are applicable may
 
not always be feasible, we propose recommendations
 
for improvements that should be standard practices of
 
surveillance programs. We also propose recommended
practices that expand on these basic improvements, to be
implemented where possible.
The purpose of public health surveillance is to serve as
a foundation for action to improve health, but the use
of surveillance data may be limited if surveillance is
ineffective.  For surveillance data to be effective, HIV
infection must be diagnosed. Even when surveillance
is effective, its use may be limited. Therefore, the
recommendations below address both identification of
infection and use of surveillance data, and are directed
toward health department HIV testing and prevention
programs as well as surveillance programs. To fulfill the
purpose of HIV surveillance among AI/AN, state health
departments must work continuously to develop and
improve relationships with Tribal governments, IHS,
and non-governmental AI/AN-serving HIV prevention
programs and care services, and implement these recom­
mendations with their input and collaboration.
1. Improve ascertainment of infection (case
 
identification)
 
Standard practice: 
•	 Promote protocols for routine, opt-out HIV
testing in accordance with CDC’s Revised Recom­
mendations for HIV Testing of Adults, Adolescents
and Pregnant Women in Health-Care Settings.35 
 Recommended practice: 
•	 Expand testing and encourage testing outreach to
AI/AN persons through AI/AN Tribes, agencies,
and organizations. 
•	 Utilize available culturally appropriate “know
your status” and HIV awareness materials directed
toward AI/AN.
Information on testing programs and National
Native HIV/AIDS Awareness Day toolkits are
available from sources such as: 
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» Commitment to Action for 7th-Generation
Awareness & Education (CA7AE) HIV/AIDS
Prevention Project: http://www.happ.colostate. 
edu/nad.html; 
» National Native American AIDS Prevention
Center: http://www.nnaapc.org/resources/ 
promotehivtesting.htm. 
» Northern Plains Tribal Epidemiology Center:
http://gptchb.org/nptec/stdhivaids.php?page=3 
» Northwest Portland Area Indian Health Board:
http://www.npaihb.org/epicenter/project/ 
project_red_talon/ 
2. Improve reporting of diagnoses 
Standard practice: 
•	 Identify providers serving AI/AN patients,
including social service providers, community
based organizations (CBOs), and laboratories
conducting HIV testing of AI/AN persons, and
follow up to encourage the reporting of all positive
HIV tests to local or state health departments. 
Recommended practice:
•	 Present AI/AN HIV surveillance information to
AI/AN Tribes, agencies, and organizations, and
emphasize the importance of complete reporting,
including reporting of risk factors, for improved
usefulness of the data. 
•	 Promote HIV case reporting by facilities serving
AI/AN persons, including establishment of
agreements between state health departments and
tribal and community-based organizations that
perform HIV testing. Conduct special studies to
evaluate completeness of reporting. 
•	 Develop formal data sharing agreements between
state health departments, IHS/Tribal/Urban
health facilities (I/T/U) and tribal organizations,
in accordance with current data security and
confidentiality guidelines, to strengthen
 
collaboration on surveillance.
 
3. Reduce racial/ethnic misidentification 
Standard practice: 
•	 Present, in surveillance reports, cases with
documented single AI/AN race (AI/AN only
without Hispanic ethnicity), and, separately,
present AI/AN cases with and without Hispanic
ethnicity. 
Recommended practice: 
•	 Identify ways to encourage more accurate
 
documentation of race/ethnicity in medical
 
records.
 
•	 Utilize data sources with self-reported or family-
reported race, such as Ryan White program data,
to improve the completeness and accuracy of race/ 
ethnicity in surveillance data.
•	 Contact providers for race/ethnicity information
when the case report indicates non-AI/AN race
and diagnosis has occurred in an IHS-funded, AI/ 
AN-focused CBO, or tribally operated facility, or
there is other information suggestive of AI/AN
race. 
•	 Partner with Tribes, IHBs, TECs and IHS to
identify and correct misidentification of race/ 
ethnicity by periodically linking HIV surveillance
data with tribal membership rolls or the IHS
patient registration system.
4. Improve analysis and presentation of data 
Standard practice: 
•	 Analyze and present summary information on
HIV among AI/AN annually, separately from
other races/ethnicities, if numbers of AI/AN cases
are deemed sufficiently large, according to data
release guidelines.33,36 Otherwise, combine data
across years.
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Recommended practice: 
•	 Work with AI/AN Tribes, IHBs, and TECs as well as
non-governmental AI/AN-serving organizations to
identify HIV surveillance information needed and
address these needs. 
•	 Produce and disseminate AI/AN-focused HIV reports
or fact sheets using local HIV surveillance data. 
•	 Partner with Tribes, IHBs, AI/AN-focused CBOs and
TECs to conduct within-jurisdiction regional analyses
that cover areas of high concentration of AI/AN
people. 
•	 Collaborate with other states and Tribes, IHBs, AI/ 
AN-focused CBOs, and TECs, to combine data for
broader regional analyses of AI/AN HIV surveillance
data. 
5. Improve dissemination of data 
Standard practice: 
•	 Send AI/AN HIV surveillance reports and summary
information directly to AI/AN Tribes, agencies, and
organizations that have expressed a need for this
information. 
Recommended practice: 
•	 Proactively identify and offer assistance to AI/ 
AN Tribes, agencies, and organizations that have
information needs and/or need technical assistance or
capacity building assistance related to interpreting and
using HIV surveillance data. 
•	 Promote the use of AI/AN HIV surveillance data
through presentations to HIV prevention planning
groups, health care providers that serve AI/AN, and
AI/AN-focused prevention programs 
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